Home The PCSK9 gene E670G polymorphism affects low-density lipoprotein cholesterol levels but is not a risk factor for coronary artery disease in ethnic Chinese in Taiwan
Article
Licensed
Unlicensed Requires Authentication

The PCSK9 gene E670G polymorphism affects low-density lipoprotein cholesterol levels but is not a risk factor for coronary artery disease in ethnic Chinese in Taiwan

  • Lung-An Hsu , Ming-Sheng Teng , Yu-Lin Ko , Chi-Jen Chang , Semon Wu , Chun-Li Wang and Chiao-Feng Hu
Published/Copyright: February 1, 2009

Abstract

Background: An E670G polymorphism of the exon 12 of the proprotein convertase subtilisin/kexin type 9 (PCSK9) gene was recently found to be associated with increased plasma low-density lipoprotein cholesterol (LDL-C) levels and severity of coronary atherosclerosis. This case-control study tested for a possible link between this PCSK9 polymorphism and the risk of coronary artery disease (CAD) in an ethnic Chinese population in Taiwan.

Methods: The subjects included 202 CAD patients and 614 unrelated controls. Genotypes were determined via polymerase chain reaction, restriction mapping with MboII, and gel electrophoresis.

Results: Contradictory to the results of a previous report, a significantly lower level of LDL-C was noted in 670G carriers than in non-carriers (2.78±0.82 mmol/L vs. 3.02±0.85 mmol/L; p=0.029) among controls, after adjusting for age, gender, smoking, hypertension, diabetes mellitus, body mass index, and use of lipid-lowering agents. The 670G carrier was identified less frequently in patients with CAD than in controls (9.9% vs. 11.9%), but the difference was not significant in a multivariable logistic regression analysis (odds ratio=0.73; 95% CI=0.24–2.22; p=0.575). The G allele also occurred at similar frequencies in the two groups (5.0% vs. 6.0%; p=0.421).

Conclusions: These results indicate that the E670G polymorphism of the PCSK9 gene modulates plasma LDL-C levels, but that it is not a risk variant for CAD in ethnic Chinese in Taiwan.

Clin Chem Lab Med 2009;47:154–8.


a

Lung-An Hsu and Ming-Sheng Teng contributed equally to this work.

Corresponding author: Lung-An Hsu, MD, PhD, The First Cardiovascular Division, Department of Internal Medicine, Chang Gung Memorial Hospital, No. 199, Tung Hwa North Road, Taipei, Taiwan Phone: +886-3-3281200 ext. 8162, Fax: +886-3-3271192,

Received: 2008-7-16
Accepted: 2008-10-16
Published Online: 2009-02-01
Published in Print: 2009-02-01

©2009 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorial
  2. 50th Anniversary of SBCC/BVKC: “International Symposium Brussels 2008: New Trends in Clinical Biology. Emerging Technologies and their Impact on Laboratory Medicine and Management”
  3. Reviews
  4. Vitamin D: current status and perspectives
  5. Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk?
  6. New European guidelines for cardiovascular disease prevention in clinical practice
  7. Review
  8. Causes, consequences, detection, and prevention of identification errors in laboratory diagnostics
  9. Genetics and Molecular Diagnostics
  10. The PCSK9 gene E670G polymorphism affects low-density lipoprotein cholesterol levels but is not a risk factor for coronary artery disease in ethnic Chinese in Taiwan
  11. Polymorphisms and plasma soluble levels of E-selectin in patients with chronic hepatitis B virus infection
  12. General Clinical Chemistry and Laboratory Medicine
  13. Effect of high levels of human chorionic gonadotropin and estradiol on the severity of hyperemesis gravidarum
  14. Freeze-thaw and matrix effects in direct high-density lipoprotein cholesterol methods
  15. Methodology for monitoring cytomegalovirus infection after renal transplantation
  16. High concentrations of haptocorrin interfere with routine measurement of cobalamins in human serum and milk. A problem and its solution
  17. Reference Values and Biological Variations
  18. Inter- and intra-individual variations of urinary endogenous metabolites in healthy male college students using 1H NMR spectroscopy
  19. Preanalytical errors in primary healthcare: a questionnaire study of information search procedures, test request management and test tube labelling
  20. Age and hormone replacement therapy as factors influencing androgen levels in the postmenopausal female
  21. Preheparin serum lipoprotein lipase mass interacts with gender, gene polymorphism and, positively, with smoking
  22. Validation and Outcome Studies
  23. Comparison of calcium, magnesium, sodium, potassium, zinc, and creatinine concentration in 24-h and spot urine samples in women
  24. Performance of free β-human chorionic gonadotrophin (free β-hCG) and pregnancy associated plasma protein-A (PAPP-A) analysis between Delfia Xpress and AutoDelfia systems in The Netherlands
  25. A pilot survey of the use and implementation of cardiac markers in acute coronary syndrome and heart failure across Europe The CARdiac MArker Guideline Uptake in Europe (CARMAGUE) study
  26. Letters to the Editor
  27. Interference of IgM-λ paraprotein with biuret-type assay for total serum protein quantification
  28. Evaluation of BD Vacutainer® PST™II tubes for a wide range of immunoassays
  29. Native prothrombin as an alternative to prothrombin time determination for monitoring oral anticoagulant therapy
Downloaded on 28.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2009.032/html
Scroll to top button